Compound ID |
Compound Name |
Compound Formula |
CP0037352
|
(3S)-3-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(3S)-3-amino-3-formamidopropanoic acid]-3-[4-(sulfooxy)phenyl]propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid
Show/Hide
|
C49H62N10O16S3
|
5
|
1 |
EC50 = 0.1 nM
|
|
|
2 |
IC50 = 0.389 nM
|
|
|
3 |
IC50 = 0.631 nM
|
|
|
4 |
IC50 = 1.259 nM
|
|
|
5 |
IC50 = 1.318 nM
|
|
|
CP0340102
|
4-[[(2R)-1-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexan-2-yl]amino]-4-oxobutanoic acid
Show/Hide
|
C41H54N6O7
|
2
|
1 |
EC50 = 3.162 nM
|
|
|
2 |
IC50 = 12.02 nM
|
|
|
CP0326463
|
(S)-3-[(S)-2-[(S)-2-Acetylamino-3-(1H-indol-3-yl)-propionylamino]-6-(3-o-tolyl-ureido)-hexanoylamino]-N-((S)-1-carbamoyl-2-phenyl-ethyl)-N-methyl-succinamic acid
Show/Hide
|
C41H50N8O8
|
2
|
1 |
EC50 = 3.981 nM
|
|
|
2 |
IC50 = 19.95 nM
|
|
|
CP0041613
|
Anapriline
Show/Hide
|
C16H21NO2
|
2
|
1 |
EC50 > 5011.87 nM
|
|
|
2 |
IC50 > 5011.87 nM
|
|
|
CP0066236
|
1-(dimethylamino)-3-[(2-methyl-1H-1,2-benzazaborinin-8-yl)oxy]propan-2-ol
Show/Hide
|
C14H21BN2O2
|
2
|
1 |
EC50 > 5011.87 nM
|
|
|
2 |
IC50 > 5011.87 nM
|
|
|
CP0366351
|
1-(dimethylamino)-3-[(2-methyl-1H-1,2-benzazaborinin-5-yl)oxy]propan-2-ol
Show/Hide
|
C14H21BN2O2
|
2
|
1 |
EC50 > 5011.87 nM
|
|
|
2 |
IC50 > 5011.87 nM
|
|
|
CP0403059
|
methyl 2-[[2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]carbamoyl]indole-1-carboxylate
Show/Hide
|
C37H33N5O6
|
1
|
1 |
IC50 = 10 nM
|
|
|
CP0527495
|
N-[2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-1H-indole-2-carboxamide
Show/Hide
|
C35H31N5O4
|
1
|
1 |
IC50 = 15.85 nM
|
|
|
CP0467375
|
2-[3-ethyl-2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide
Show/Hide
|
C36H36N4O4
|
1
|
1 |
IC50 = 36.31 nM
|
|
|
CP0460799
|
2-[2,4-dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-(4-hydroxyphenyl)-N-propan-2-ylacetamide
Show/Hide
|
C33H31N5O5
|
1
|
1 |
IC50 = 39.81 nM
|
|
|
CP0208808
|
1-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)-3-phenylurea
Show/Hide
|
C33H31N5O4
|
2
|
1 |
IC50 = 50.12 nM
|
|
|
2 |
IC50 = 54.95 nM
|
|
|
CP0398472
|
4-[[(2S)-2-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexyl]amino]-4-oxobutanoic acid
Show/Hide
|
C41H54N6O7
|
1
|
1 |
IC50 = 60.26 nM
|
|
|
CP0923053
|
N-(4-Dimethylamino-phenyl)-2-[2,4-dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl]-N-isopropyl-acetamide TFA
Show/Hide
|
C37H37F3N6O6
|
1
|
1 |
IC50 = 63.1 nM
|
|
|
CP0101581
|
2-[3-methyl-2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide
Show/Hide
|
C35H34N4O4
|
1
|
1 |
IC50 = 75.86 nM
|
|
|
CP0424130
|
2-[2,4-Dioxo-5-phenyl-3-(3-phenyl-ureido)-2,3,4,5-tetrahydro-benzo[b][1,4]diazepin-1-yl]-N-isopropyl-N-(4-methoxy-phenyl)-acetamide
Show/Hide
|
C34H33N5O5
|
1
|
1 |
IC50 = 79.43 nM
|
|
|
CP0380382
|
2-[2,4-dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-(4-fluorophenyl)-N-propan-2-ylacetamide
Show/Hide
|
C33H30FN5O4
|
1
|
1 |
IC50 = 100 nM
|
|
|
CP0843275
|
3-(3-{1-[(Isopropyl-phenyl-carbamoyl)-methyl]-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl}-ureido)-benzoic acid
Show/Hide
|
C34H31N5O6
|
1
|
1 |
IC50 = 125.89 nM
|
|
|
CP0302171
|
2-[2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide
Show/Hide
|
C34H32N4O4
|
1
|
1 |
IC50 = 154.88 nM
|
|
|
CP0418992
|
4-[[(2R)-1-[[(2S)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexan-2-yl]amino]-4-oxobutanoic acid
Show/Hide
|
C41H54N6O7
|
1
|
1 |
IC50 = 229.09 nM
|
|
|
CP0373683
|
(4R)-5-(N-[2-(4-methoxy-N-propan-2-ylanilino)-2-oxoethyl]anilino)-5-oxo-4-(phenylcarbamoylamino)pentanoic acid
Show/Hide
|
C30H34N4O6
|
1
|
1 |
IC50 = 251.19 nM
|
|
|
CP0378374
|
2-[3-benzyl-2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]-N-phenylacetamide
Show/Hide
|
C41H38N4O4
|
1
|
1 |
IC50 = 389.05 nM
|
|
|
CP0464819
|
4-[[(2S)-2-[[(2S)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-6-[(2-methylphenyl)carbamoylamino]hexyl]amino]-4-oxobutanoic acid
Show/Hide
|
C41H54N6O7
|
1
|
1 |
IC50 = 724.44 nM
|
|
|
CP0100788
|
4-[[(1R)-2-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid
Show/Hide
|
C35H42N4O6
|
1
|
1 |
IC50 = 1047.13 nM
|
|
|
CP0424987
|
2-[3-methyl-2,4-dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide
Show/Hide
|
C34H33N5O4
|
1
|
1 |
IC50 = 1318.26 nM
|
|
|
CP0431640
|
(4R)-5-oxo-5-(N-[2-oxo-2-(N-propan-2-ylanilino)ethyl]anilino)-4-(phenylcarbamoylamino)pentanoic acid
Show/Hide
|
C29H32N4O5
|
1
|
1 |
IC50 = 1584.89 nM
|
|
|
CP0421473
|
2-[2,4-dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]-N-(4-morpholin-4-ylphenyl)-N-propan-2-ylacetamide
Show/Hide
|
C37H38N6O5
|
1
|
1 |
IC50 = 1995.26 nM
|
|
|
CP0380803
|
4-[[2-[2,4-dioxo-5-phenyl-3-(phenylcarbamoylamino)-1,5-benzodiazepin-1-yl]acetyl]-propan-2-ylamino]benzoic acid
Show/Hide
|
C34H31N5O6
|
1
|
1 |
IC50 = 2511.89 nM
|
|
|
CP0409031
|
N-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-N-phenyl-2-(phenylcarbamoylamino)acetamide
Show/Hide
|
C26H28N4O3
|
1
|
1 |
IC50 = 3162.28 nM
|
|
|
CP0160764
|
(R)-1-(1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-3-(3-(methylamino)phenyl)urea
Show/Hide
|
C28H30N6O3
|
1
|
1 |
Ki = 28.84 nM
|
|
|
CP0920847
|
4-(1-cyclohexyl-5-(3,3-dimethyl-2-oxo-butyl)-2,4-dioxo-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-N-(3-(5-oxo-2,5-dihydro-[1,2,4]oxadiazol-3-yl)-phenyl)-butyramide
Show/Hide
|
C32H38N6O6
|
1
|
1 |
Ki = 72.44 nM
|
|
|
CP0877927
|
2-(1-cycloheptyl-5-(3,3-dimethyl-2-oxo-butyl)-2,4-dioxo-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-N-(3-(5-oxo-2,5-dihydro-[1,2,4]oxadiazol-3-yl)-phenyl)-acetamide
Show/Hide
|
C31H36N6O6
|
1
|
1 |
Ki = 117.49 nM
|
|
|
CP0877928
|
(3-(2-(1-cycloheptyl-5-(3,3-dimethyl-2-oxo-butyl)-2,4-dioxo-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-acetylamino)-phenylsulfanyl)-acetic acid
Show/Hide
|
C31H38N4O6S
|
1
|
1 |
Ki = 281.84 nM
|
|
|
CP0873275
|
2-(1-cyclohexyl-5-(3,3-dimethyl-2-oxo-butyl)-2,4-dioxo-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-N-(3-(5-oxo-2,5-dihydro-[1,2,4]oxadiazol-3-yl)-phenyl)-acetamide
Show/Hide
|
C30H34N6O6
|
1
|
1 |
Ki = 316.23 nM
|
|
|
CP0377897
|
2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]-N-[3-(2H-tetrazol-5-ylmethylsulfanyl)phenyl]acetamide
Show/Hide
|
C30H36N8O3S
|
1
|
1 |
Ki = 389.05 nM
|
|
|
CP0893510
|
2-(1-cycloheptyl-5-(3,3-dimethyl-2-oxo-butyl)-2,4-dioxo-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-N-mtolyl-acetamide
Show/Hide
|
C30H38N4O4
|
1
|
1 |
Ki = 446.68 nM
|
|
|
CP0486206
|
5-[3-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]phenyl]furan-2-carboxylic acid
Show/Hide
|
C33H36N4O6
|
1
|
1 |
Ki = 457.09 nM
|
|
|
CP0460085
|
2-[5-cyclohexyl-1-(2-cyclopentyl-2-oxoethyl)-2-oxo-1,3,4-benzotriazepin-3-yl]-N-[3-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]acetamide
Show/Hide
|
C31H34N6O5
|
1
|
1 |
Ki = 467.74 nM
|
|
|
CP0445844
|
2-[6-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]indol-1-yl]acetic acid
Show/Hide
|
C32H37N5O5
|
1
|
1 |
Ki = 549.54 nM
|
|
|
CP0463042
|
3-[3-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]phenyl]benzoic acid
Show/Hide
|
C35H38N4O5
|
1
|
1 |
Ki = 549.54 nM
|
|
|
CP0377905
|
2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]-N-[3-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]acetamide
Show/Hide
|
C30H34N6O5
|
1
|
1 |
Ki = 588.84 nM
|
|
|
CP0886067
|
2-(1-cycloheptyl-2,4-dioxo-5-(2-oxo-2-pyrrolidin-1-yl-ethyl)-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-N-m-tolyl-acetamide
Show/Hide
|
C30H37N5O4
|
1
|
1 |
Ki = 616.6 nM
|
|
|
CP0463035
|
2-[3-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]phenyl]-1,3-oxazole-4-carboxylic acid
Show/Hide
|
C32H35N5O6
|
1
|
1 |
Ki = 660.69 nM
|
|
|
CP0886040
|
2-(1-cyclohexyl-5-(3,3-dimethyl-2-oxo-butyl)-2,4-dioxo-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-N-(3-(2-methyl-thiazol-4-yl)-phenyl)-acetamide
Show/Hide
|
C32H37N5O4S
|
1
|
1 |
Ki = 1548.82 nM
|
|
|
CP0437077
|
2-[4-[3-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]phenyl]imidazol-1-yl]acetic acid;hydrochloride
Show/Hide
|
C33H38N6O5
|
1
|
1 |
Ki = 1698.24 nM
|
|
|
CP0377904
|
2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]-N-[3-(2H-tetrazol-5-yl)phenyl]acetamide
Show/Hide
|
C29H34N8O3
|
1
|
1 |
Ki = 1737.8 nM
|
|
|
CP0434220
|
2-[3-[[2-[5-cyclohexyl-1-(2-cyclopentyl-2-oxoethyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]phenyl]sulfanylacetic acid
Show/Hide
|
C31H36N4O5S
|
1
|
1 |
Ki = 2089.3 nM
|
|
|
CP0939854
|
2-(1-cyclohexyl-5-(3,3-dimethyl-2-oxo-butyl)-2,4-dioxo-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-N-(3-(methyl-(2H-tetrazol-5-yl)-amino)-phenyl)-acetamide
Show/Hide
|
C30H37N9O4
|
1
|
1 |
Ki = 2089.3 nM
|
|
|
CP0435649
|
2-[6-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]indazol-1-yl]acetic acid
Show/Hide
|
C31H36N6O5
|
1
|
1 |
Ki = 2137.96 nM
|
|
|
CP0897677
|
3-(3-(2-(1-cyclohexyl-5-(3,3-dimethyl-2-oxo-butyl)-2,4-dioxo-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-acetylamino)-phenyl)-propionic acid
Show/Hide
|
C31H38N4O6
|
1
|
1 |
Ki = 2344.23 nM
|
|
|
CP0914890
|
2-(1-cyclohexyl-5-(3,3-dimethyl-2-oxo-butyl)-2,4-dioxo-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-N-(3-methylamino-phenyl)-acetamide
Show/Hide
|
C29H37N5O4
|
1
|
1 |
Ki = 2344.23 nM
|
|
|
CP0445843
|
3-[3-[[2-[5-cyclohexyl-1-(2-cyclopentyl-2-oxoethyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]phenyl]propanoic acid
Show/Hide
|
C32H38N4O5
|
1
|
1 |
Ki = 2511.89 nM
|
|
|
CP0445846
|
2-[5-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]indol-1-yl]acetic acid
Show/Hide
|
C32H37N5O5
|
1
|
1 |
Ki = 2511.89 nM
|
|
|
CP0897678
|
(3-(2-(1-cycloheptyl-5-(3,3-dimethyl-2-oxo-butyl)-2,4-dioxo-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-acetylamino)-phenyl)-acetic acid
Show/Hide
|
C31H38N4O6
|
1
|
1 |
Ki = 3890.45 nM
|
|
|
CP0435583
|
3-[[2-[5-cyclohexyl-1-[2-(2-methylcyclopentyl)-2-oxoethyl]-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]benzoic acid
Show/Hide
|
C31H36N4O5
|
1
|
1 |
Ki = 3981.07 nM
|
|
|
CP0460084
|
2-[3-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]-N-methylanilino]acetic acid
Show/Hide
|
C31H39N5O5
|
1
|
1 |
Ki = 6456.54 nM
|
|
|
CP0374448
|
2-[4-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]indazol-1-yl]acetic acid;2,2,2-trifluoroacetic acid
Show/Hide
|
C31H36N6O5
|
1
|
1 |
Ki = 6918.31 nM
|
|
|
CP0463044
|
3-[[2-[5-cyclohexyl-1-(2-cyclohexyl-2-oxoethyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]benzoic acid
Show/Hide
|
C31H36N4O5
|
1
|
1 |
Ki = 7943.28 nM
|
|
|
CP0460088
|
2-[5-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]indazol-1-yl]acetic acid
Show/Hide
|
C31H36N6O5
|
1
|
1 |
Ki = 8128.31 nM
|
|
|
CP0475203
|
3-[3-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]phenyl]propanoic acid
Show/Hide
|
C31H38N4O5
|
1
|
1 |
Ki > 10000 nM
|
|
|
CP0377906
|
2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]-N-[3-(2H-tetrazol-5-ylmethyl)phenyl]acetamide
Show/Hide
|
C30H36N8O3
|
1
|
1 |
Ki < 10000 nM
|
|
|
CP0377907
|
4-[3-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]phenyl]-1,3-thiazole-2-carboxylic acid
Show/Hide
|
C32H35N5O5S
|
1
|
1 |
Ki < 10000 nM
|
|
|
CP0384959
|
2-[4-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]indol-1-yl]acetic acid
Show/Hide
|
C32H37N5O5
|
1
|
1 |
Ki < 10000 nM
|
|
|
CP0434221
|
2-[3-[[2-[5-cyclohexyl-1-(2-cyclopentyl-2-oxoethyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]phenyl]acetic acid
Show/Hide
|
C31H36N4O5
|
1
|
1 |
Ki < 10000 nM
|
|
|
CP0445845
|
2-[6-[[2-[5-cyclohexyl-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-1,3,4-benzotriazepin-3-yl]acetyl]amino]benzimidazol-1-yl]acetic acid;hydrochloride
Show/Hide
|
C31H36N6O5
|
1
|
1 |
Ki < 10000 nM
|
|
|
CP0893511
|
3-(2-(2,4-dioxo-1-(2-oxo-2-pyrrolidin-1-yl-ethyl)-5-phenyl-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-acetylamino)-benzoic acid
Show/Hide
|
C29H27N5O6
|
1
|
1 |
Ki < 10000 nM
|
|
|
CP0914889
|
2-(2,4-dioxo-1-(2-oxo-2-pyrrolidin-1-yl-ethyl)-5-phenyl-1,2,4,5-tetrahydro-1,3,5-benzotriazepin-3-yl)-N-phenylacetamide
Show/Hide
|
C28H27N5O4
|
1
|
1 |
Ki < 10000 nM
|
|
|